Stay updated on Obeldesivir Study in High-risk COVID-19: Clinical Trial
Sign up to get notified when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.

Latest updates to the Obeldesivir Study in High-risk COVID-19: Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Clin Infect Dis publication on BIRCH (2026) and removed older funding notice.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding lapse and NIH operating status with links to cc.nih.gov and opm.gov. Updated the site to revision v3.4.1, replacing v3.4.0.SummaryDifference0.3%

- Check28 days agoChange DetectedThe page now includes a glossary option, adds a new cited publication (SARS-CoV-2 Resistance Analyses...), and updates several metadata labels including QC-related entries and the revision tag.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 removed. This is a minor metadata update to the page.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a new Locations section including Łódź Voivodeship; removed the Łódź Voivodeship Locations entry; updated page revision from v3.3.2 to v3.3.3.SummaryDifference0.1%

- Check85 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2; no substantive changes to the study details, locations, or eligibility criteria are visible on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Obeldesivir Study in High-risk COVID-19: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Obeldesivir Study in High-risk COVID-19: Clinical Trial page.